Adherium Ltd Total Liabilities

Latest as of December 2025: AU$4.94 Million AUD ≈ $3.50 Million USD

Adherium Ltd total liabilities. Based on the latest financial reports, Adherium Ltd (ADR) has total liabilities worth AU$4.94 Million AUD (≈ $3.50 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check financial resilience of Adherium Ltd to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Adherium Ltd (2012–2025)

Total liabilities of Adherium Ltd from 2012 to 2025. This chart illustrates how Adherium Ltd's total liabilities have evolved over time, based on quarterly financial data.

Adherium Ltd Competitors by Total Liabilities

The table below lists competitors of Adherium Ltd ranked by their total liabilities.

Company Country Total Liabilities
Begbies Traynor Group PLC
LSE:BEG
UK GBX83.60 Million
Thai Setakij Insurance PCL
BK:TSI
Thailand ฿949.34 Million
Merko Gida Sanayi ve Ticaret AS
IS:MERKO
Turkey TL953.48 Million
MRG Metals Ltd
AU:MRQ
Australia AU$182.35K
Precomp Solutions AB Series B
ST:PCOM-B
Sweden Skr72.30 Million
Vast Renewables Limited Ordinary Shares
NASDAQ:VSTE
USA $24.07 Million
Planet Properindo Jaya Pt
JK:PLAN
Indonesia Rp25.82 Billion
Innovotech Inc
V:IOT
Canada CA$993.81K

Liability Composition Analysis (2012–2025)

This chart breaks down Adherium Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Adherium Ltd asset portfolio.

Liquidity & Leverage Metrics

Adherium Ltd Total Liabilities Ratios Explained

Adherium Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 0.82 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio 0.13 Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity -6.28 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 1.19 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Adherium Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Adherium Ltd (2012–2025)

The table below shows the annual total liabilities of Adherium Ltd from 2012 to 2025.

Year Total Liabilities Change
2025-06-30 AU$8.28 Million
≈ $5.86 Million
+143.01%
2024-06-30 AU$3.41 Million
≈ $2.41 Million
-1.74%
2023-06-30 AU$3.47 Million
≈ $2.45 Million
+15.72%
2022-06-30 AU$3.00 Million
≈ $2.12 Million
-0.27%
2021-06-30 AU$3.00 Million
≈ $2.13 Million
-9.90%
2020-06-30 AU$3.33 Million
≈ $2.36 Million
+135.79%
2019-06-30 AU$1.41 Million
≈ $1.00 Million
-43.69%
2018-06-30 AU$2.51 Million
≈ $1.78 Million
+5.24%
2017-06-30 AU$2.39 Million
≈ $1.69 Million
+59.28%
2016-06-30 AU$1.50 Million
≈ $1.06 Million
-42.93%
2015-06-30 AU$2.62 Million
≈ $1.86 Million
+320.62%
2014-06-30 AU$624.09K
≈ $441.58K
-6.43%
2014-03-31 AU$667.00K
≈ $471.94K
+440.92%
2013-06-30 AU$123.31K
≈ $87.25K
+18.57%
2012-06-30 AU$104.00K
≈ $73.59K
--

About Adherium Ltd

AU:ADR Australia Medical Devices
Market Cap
$2.37 Million
AU$3.35 Million AUD
Market Cap Rank
#29793 Global
#1702 in Australia
Share Price
AU$0.06
Change (1 day)
-8.96%
52-Week Range
AU$0.00 - AU$0.20
All Time High
AU$10.31
About

Adherium Limited, a digital health company, develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, and North America. The company offers Hailie Smartinhaler, a system for management of chronic respiratory conditions, including asthma and chronic obstructive pulmonary disease. It also provides … Read more